Biomapas appoints Head of Global Regulatory Affairs

May 2020 Olga Bernardova joins Biomapas as Head of Global Regulatory Affairs to lead the regulatory affairs department and to ensure the best processes and means to serve Biomapas growth and international expansion.

As a functional and full outsourcing solution provider, with offices in Lithuania, Switzerland, Sweden, Russia, Georgia, Ukraine, Poland and Kazakhstan, Biomapas continues to expand its international team and further increases capabilities for client-oriented solution delivery.

Olga Bernardova brings over a decade of regulatory affairs experience, previously acting as Associate Director for Europe at ProductLife Group, and further back in her career working as Coordinator for Central Europe and the Baltics at Kohne Pharma, Regulatory Affairs and Pharmacovigilance Manager at Lundbeck, Associate Regulatory Affairs Manager at Gilead Sciences, Junior Regulatory Manager at Bayer and as Regulatory Affairs Officer at UMC.

“Olga is an industry known regulatory affairs expert with experience in serving clients needs across the different regulatory landscapes, making her an outstanding addition to our leadership team,” said Juozas Buitkus, Biomapas COO. “She brings the focus of Biomapas values and demonstrates expertise in regulatory affairs, understanding the importance of local experts network for the industry needs.”

Olga Bernardova will play an important role in the implementation of Biomapas strategic goals, ensuring the geographical expansion of functional and full outsourcing solutions and maximizing the efficiency of regulatory activities in 51 countries. Olga will be responsible for the provision of the regulatory affairs department and the regulatory service portfolio development.

“She is a proven leader in the life science industry and has a history of success in the coordination of regulatory activities and life cycle management for medicinal products. Her strong background in the industry strengthens our focus on the delivery of regulatory solutions to set new standards for customer service and satisfaction even more,” said Audrius Sveikata, Biomapas CEO.

Olga Bernardova graduated from the Charles University with a specialization in Physical Chemistry. Since 2005, she works in the life science industry concentrating on regulatory affairs and management of the life cycle for medicinal products. As a proven leader in regulatory affairs, Olga Bernardova has in-depth experience at regional and international level regulatory activities guidance and implementation.

About Biomapas

Biomapas is a functional and full outsourcing solution provider to the global life science industry, with key expertise in Clinical Trials, Regulatory Affairs and Pharmacovigilance. The company has a significant presence across the CEE, Nordic and CIS countries thereby offering fast and reliable patient recruitment for Phase I-IV and medical device clinical trials, while regulatory and pharmacovigilance services are provided across 5 continents. We are committed to customer service and satisfaction.

Clinical Trials Regulation Guide

Get our useful resource for sponsors and investigators to navigate the various aspects of clinical trial conduct and to provide guidance on how to comply with the requirements of the CTR.

By following the steps outlined in this guide, sponsors and investigators can ensure that their clinical trials are conducted safely, efficiently, and in compliance with regulatory requirements.

Big Enough To Cover  All Your Needs. Small Enough To Care.

Discover the tailored solutions that Biomapas provides to accelerate your clinical trials and optimize your drug development process.

Clinical Research

Regulatory Affairs


Medical Information